Effects of CpG-DNA from Escherichia coli on digoxin pharmacokinetics

Biological and Pharmaceutical Bulletin

Volumn 31, Issue 6, 2008, Pages 1226-1229

  Kato, Ryuji ^a   Tokunaga, Yuka ^a   Kawai, Takako ^a   Tsukura, Yuri ^a   Amano, Fumio ^a   Hirotani, Yoshihiko ^b   Ijiri, Yoshio ^a   Tanaka, Kazuhiko ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b OSAKA OHTANI UNIVERSITY   (Japan)

Author keywords

Absorption; CpG DNA; Digoxin; Distribution

Indexed keywords

CPG DNA; DIGOXIN; DNA; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; NITRATE; NITRITE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; ESCHERICHIA COLI; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; RAT;

ANIMALS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CARDIOTONIC AGENTS; CPG ISLANDS; DIGOXIN; DNA, BACTERIAL; ESCHERICHIA COLI; INTERLEUKIN-1BETA; MALE; NITRATES; NITRITES; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 45749134270     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.31.1226     Document Type: Article

References (17)

1. Bone R. C., Grodzin C. J., Balk R. A., Chest, 112, 235-243 (1997).
2. Bune A. J., Brand M. P., Heales S. J., Shergill J. K., Cammack R., Cook H. T., Biochem. Biophys. Res. Commun., 220, 13-19 (1996).
3. Thiemermann C., Wu C. C., Szabo C., Perretti M., Vane J. R., Br. J. Pharmacol., 110, 177-182 (1993).
4. Ikejima K., Iimuro Y., Forman D. T., Thurman R. G., Am. J. Physiol., 271, G97-G103 (1996).
5. Hattori Y., Murakami Y., Atsuta H., Minamino N., Kangawa K., Kasai K., Life Sci., 62, 181-189 (1998).
6. Hong K. W., Kim K. E., Rhim B. Y., Lee W. S., Kim C. D., Dig. Dis. Sci., 48, 154S-159S (1998).
7. Akira S., Uematsu S., Takeuchi O., Cell, 124, 783-801 (2006).
8. Kalitsky-Szirtes J., Shayeganpour A., Brocks D. R., Piquette-Miller M., Drug Metab. Dispos., 32, 20-27 (2004).
9. Bock H. A., Kidney Int., 64, S15-S18 (1998).
10. Moriguchi J., Kato R., Nakagawa M., Hirotani Y., Ijiri Y., Tanaka K., Eur. J. Pharmacol., 565, 220-224 (2007).
11. Harrison L. I., Gibaldi M., Drug Metab. Dispos., 4, 88-93 (1976).
12. Hartmann G., Krieg A. M., Gene Ther., 6, 893-903 (1999).
13. Kitaichi K., Nakayama H., Ueyama J., Nadai M., Baba K., Takagi Kenj., Takagi Kenz., Ohta M., Hasegawa T., Biochem. Pharmacol., 67, 1427-1435 (2004).
14. Kitaichi K., Wang L., Takagi K., Iwase M., Shibata E., Nadai M., Hasegawa T., Antimicrob. Agents Chemother., 43, 2697-2701 (1999).
15. Takemura S., Minamiyama Y., Imaoka S., Funae Y., Hirohashi K., Inoue M., Kinoshita H., J. Hepatol., 30, 1035-1044 (1999).
16. Ideura T., Yoshimura A., Shirai M., Taira T., Koshikawa S., Scand. J. Urol. Nephrol., 27, 433-439 (1993).
17. Harrison L. I., Gibaldi M., J. Pharm. Sci., 66, 1138-1142 (1977).